Cannara Biotech Inc. Return on Equity (ROE) for the year ending August 31, 2024: 7.32%

Cannara Biotech Inc. Return on Equity (ROE) is 7.32% for the year ending August 31, 2024, a -15.95% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Cannara Biotech Inc. Return on Equity (ROE) for the year ending August 31, 2023 was 8.71%, a 152.12% change year over year.
  • Cannara Biotech Inc. Return on Equity (ROE) for the year ending August 31, 2022 was 3.45%, a -171.58% change year over year.
  • Cannara Biotech Inc. Return on Equity (ROE) for the year ending August 31, 2021 was -4.83%, a -86.59% change year over year.
  • Cannara Biotech Inc. Return on Equity (ROE) for the year ending August 31, 2020 was -35.99%, a 22.76% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share